BioLargo, Inc. (BLGO) Financials
BLGO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 6.7 million | 4.6 million |
| March 31, 2026 | 8.6 million | 8.8 million |
| Dec. 31, 2025 | 8.3 million | 6.8 million |
| Sept. 30, 2025 | 9.1 million | 5.9 million |
BLGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.0 million | 722000 |
| March 31, 2026 | -2.9 million | 699000 |
| Dec. 31, 2025 | -1.6 million | 1.0 million |
| Sept. 30, 2025 | -2.8 million | 844000 |
BLGO Net Income
No data available :(
BLGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.2 million | 946000 | - |
| March 31, 2026 | 4.1 million | 2.8 million | 1.4 million |
| Dec. 31, 2025 | 3.9 million | 601000 | 1.4 million |
| Sept. 30, 2025 | 4.5 million | 2.2 million | 1.5 million |
BLGO Shares Outstanding
BLGO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 32000 | 1.1 million | 3.3 million | - |
| March 31, 2026 | 32000 | 907000 | 2.7 million | 148000 |
| Dec. 31, 2025 | 13000 | 652000 | 3.4 million | 120000 |
| Sept. 30, 2025 | 33000 | 615000 | 3.1 million | - |
BLGO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.2 million | 573000 |
| March 31, 2026 | 1.1 million | 657000 |
| Dec. 31, 2025 | 616000 | 491000 |
| Sept. 30, 2025 | 1.1 million | 731000 |
BLGO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BLGO
Price: $0.08
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.04 USD
P/E Ratio: -4.50
Exchange: OQX
Sector: Basic Materials
Industry: Chemicals
Market Capitalization: 25.0 million